Abstract
The supernatant fluid of axenically grown E. histolytica HM-1:IMSS (and virgin axenic medium as control) was obtained by centrifugation and ultrafiltration, and applied to gel-sieve (Sephadex G15) chromatography (1). The 478– 735-Da chromatographic fraction was subjected to reverse phase HPLC-C18. Only the second of five closely emerging peaks revealed MLIF activity (absent from the virgin axenic medium) and was, in turn, subjected to mass-spectrometry: MALDI-MS (2) and tandem MS/MS (TSQ-LC-MS) (3), and Edman sequencing (4). Once the primary chemical structure was known (5), a 96% pure custom MLIF (American Peptide Corp., Sunnyvale, CA, USA) was tested in vitro (human monocyte locomotion in Boyden chambers, as well as monocyte and neutrophil respiratory burst by chemiluminescence) and in vivo (delayed hypersensitivity skin reactions to 1-chloro-2-4 dinitrobenzene in guinea pigs) alongside the native MLIF.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.